Pasadena, CA, United States of America

Calando Pharmaceuticals, Inc.


USPTO Granted Patents = 9

% Expired Patents = 100.0


Forward Citations = 188

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Mark E Davis (9 out of 137 patents)

silverMedal Jianjun Cheng (7 out of 23 patents)

bronzeMedal Suzie Hwang Pun (4 out of 7 patents)

4.  Nathalie C Bellocq (4 out of 7 patents)

5.  Hector Gonzalez (4 out of 11 patents)

6.  Kay T Khin (3 out of 15 patents)

7.  Jeremy D Heidel (2 out of 5 patents)

8.  John J Rossi (1 out of 102 patents)

9.  Joanna Yi-Ching Liu (1 out of 1 patent)

10.  John J Roosi (0 patent)


9 patents:

Company Overview
Calando Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel targeted therapies for the treatment of cancer. Using its proprietary RNA interference (RNAi) technology, Calando is dedicated to delivering personalized medicine solutions that improve patient outcomes and quality of life. With a strong pipeline of innovative oncology products, Calando is committed to advancing the field of precision medicine and revolutionizing cancer treatment.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#59 in Pasadena, CA

#7,745 in California

#32,605 in US

Pasadena, CA (US)
Pasadena, CA, United States of America
Forward Citations = 188

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Calando Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/calando-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…